Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial

Author(s):
Iacobelli, S.; Wreede, L.C. de (0000-0002-7667-9369); Schonland, S.; Bjorkstrand, B.; Hegenbart, U.; Gruber, A.; Greinix, H.; Volin, L.; Narni, F.; Carella, A.M.; Beksac, M.; Bosi, A.; Milone, G.; Corradini, P.; Friberg, K.; Biezen, A. van; Goldschmidt, H.; Witte, T. de; Morris, C.; Niederwieser, D.; Garderet, L.; Kroger, N.; Gahrton, G.; EBMT CMWP; Plasma Cell Disorders Subcomm
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-04-30
Language
English
Is part of
Bone Marrow Transplantation (2015), Vol. 50, no. 4, p. 505-510
hdl
1887/107971
doi
10.1038/bmt.2014.310